Missing/wrong data?
Log in to edit
Bromodomain inhibitor OTX015 in patients with lymphoma or multiple myeloma: a dose-escalation, open-label, pharmacokinetic, phase 1 study
scientific article
Author/s
author: Xavier Leleu, Catherine Thieblemont, François Lokiec, Keyvan Rezai, Emanuele Zucca, David Cunningham, Thierry Facon, Antonio Palumbo
Work details
Publication date
March 18, 2016
-
-
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.